Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Mar 11;3(3):CD009621.
doi: 10.1002/14651858.CD009621.pub4.

Fibrin sealants for the prevention of postoperative pancreatic fistula following pancreatic surgery

Yilei Deng  1 , Sirong He  2 , Yao Cheng  3 , Nansheng Cheng  4 , Jianping Gong  3 , Junhua Gong  5 , Zhong Zeng  5 , Longshuan Zhao  1
Affiliations
Meta-Analysis

Fibrin sealants for the prevention of postoperative pancreatic fistula following pancreatic surgery

Yilei Deng et al. Cochrane Database Syst Rev. .

Update in

Abstract

Background: Postoperative pancreatic fistula is one of the most frequent and potentially life-threatening complications following pancreatic resections. Fibrin sealants have been used in some centers to reduce postoperative pancreatic fistula. However, the use of fibrin sealants during pancreatic surgery is controversial. This is an update of a Cochrane Review last published in 2018.

Objectives: To assess the safety, effectiveness, and potential adverse effects of fibrin sealants for the prevention of postoperative pancreatic fistula following pancreatic surgery.

Search methods: We searched trial registers and the following biomedical databases: the Cochrane Library (2019, Issue 2), MEDLINE (1946 to 13 March2019), Embase (1980 to 11 March 2019), Science Citation Index Expanded (1900 to 13 March 2019), and Chinese Biomedical Literature Database (CBM) (1978 to 13 March 2019).

Selection criteria: We included all randomised controlled trials that compared fibrin sealant (fibrin glue or fibrin sealant patch) versus control (no fibrin sealant or placebo) in people undergoing pancreatic surgery.

Data collection and analysis: Two review authors independently identified the trials for inclusion, collected the data, and assessed the risk of bias. We performed the meta-analyses using Review Manager 5. We calculated the risk ratio (RR) for dichotomous outcomes (or a Peto odds ratio (OR) for very rare outcomes), and the mean difference (MD) for continuous outcomes, with 95% confidence intervals (CIs).

Main results: We included 12 studies involving 1604 participants in the review. Application of fibrin sealants to pancreatic stump closure reinforcement after distal pancreatectomy We included seven studies involving 860 participants: 428 were randomised to the fibrin sealant group and 432 to the control group after distal pancreatectomy. Fibrin sealants may lead to little or no difference in postoperative pancreatic fistula (fibrin sealant 19.3%; control 20.1%; RR 0.96, 95% CI 0.68 to 1.35; 755 participants; four studies; low-quality evidence). Fibrin sealants may also lead to little or no difference in postoperative mortality (0.3% versus 0.5%; Peto OR 0.52, 95% CI 0.05 to 5.03; 804 participants; six studies; low-quality evidence), or overall postoperative morbidity (28.5% versus 23.2%; RR 1.23, 95% CI 0.97 to 1.58; 646 participants; three studies; low-quality evidence). We are uncertain whether fibrin sealants reduce reoperation rate (2.0% versus 3.8%; RR 0.51, 95% CI 0.15 to 1.71; 376 participants; two studies; very low-quality evidence) or length of hospital stay (MD 0.99 days, 95% CI -1.83 to 3.82; 371 participants; two studies; very low-quality evidence). The studies did not report serious adverse events, quality of life, or cost effectiveness. Application of fibrin sealants to pancreatic anastomosis reinforcement after pancreaticoduodenectomy We included four studies involving 393 participants: 186 were randomised to the fibrin sealant group and 207 to the control group after pancreaticoduodenectomy. We are uncertain whether fibrin sealants reduce postoperative pancreatic fistula (16.7% versus 11.7%; RR 1.14, 95% CI 0.28 to 4.69; 199 participants; two studies; very low-quality evidence). We are uncertain whether fibrin sealants reduce postoperative mortality (0.5% versus 2.4%; Peto OR 0.26, 95% CI 0.05 to 1.32; 393 participants; four studies; low-quality evidence) or length of hospital stay (MD 0.01 days, 95% CI -3.91 to 3.94; 323 participants; three studies; very low-quality evidence). There is probably little or no difference in overall postoperative morbidity (52.6% versus 50.3%; RR 1.04, 95% CI 0.87 to 1.24; 323 participants; three studies; moderate-quality evidence) between the groups. We are uncertain whether fibrin sealants reduce reoperation rate (5.2% versus 7.7%; RR 0.74, 95% CI 0.33 to 1.66; 323 participants; three studies, very low-quality evidence). The studies did not report serious adverse events, quality of life, or cost effectiveness. Application of fibrin sealants to pancreatic duct occlusion after pancreaticoduodenectomy We included two studies involving 351 participants: 188 were randomised to the fibrin sealant group and 163 to the control group after pancreaticoduodenectomy. Fibrin sealants may lead to little or no difference in postoperative mortality (8.4% versus 6.1%; Peto OR 1.41, 95% CI 0.63 to 3.13; 351 participants; two studies; low-quality evidence) or length of hospital stay (median 16 to 17 days versus 17 days; 351 participants; two studies; low-quality evidence). We are uncertain whether fibrin sealants reduce overall postoperative morbidity (32.0% versus 27.6%; RR 1.16, 95% CI 0.67 to 2.02; 351 participants; two studies; very low-quality evidence), or reoperation rate (13.6% versus 16.0%; RR 0.85, 95% CI 0.52 to 1.41; 351 participants; two studies; very low-quality evidence). Serious adverse events were reported in one study (169 participants; low-quality evidence): more participants developed diabetes mellitus when fibrin sealants were applied to pancreatic duct occlusion, both at three months' follow-up (33.7% fibrin sealant group versus 10.8% control group; 29 participants versus 9 participants) and 12 months' follow-up (33.7% fibrin sealant group versus 14.5% control group; 29 participants versus 12 participants). The studies did not report postoperative pancreatic fistula, quality of life, or cost effectiveness.

Authors' conclusions: Based on the current available evidence, fibrin sealants may have little or no effect on postoperative pancreatic fistula in people undergoing distal pancreatectomy. The effects of fibrin sealants on the prevention of postoperative pancreatic fistula are uncertain in people undergoing pancreaticoduodenectomy.

PubMed Disclaimer

Conflict of interest statement

YD: none known.

SH: none known.

YC: none known.

NC: none known.

Jianping Gong: none known.

Junhua Gong: none known.

ZZ: none known.

LZ: none known.

Figures

1
1
Study flow diagram.
2
2
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
3
3
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
See this image and copyright information in PMC

Update of

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

Bassi 1999 {published data only}
    1. Bassi C, Butturini G, Falconi M, Salvia RNS, Caldiron E, Talamini G, et al. Prospective randomised pilot study of management of the pancreatic stump following distal resection. HPB: official journal of the International Hepato Pancreato Biliary Association 1999;1(4):203‐7.
Carter 2013 {published data only}
    1. Carter TI, Fong ZV, Hyslop T, Lavu H, Tan WP, Hardacre J, et al. A dual‐institution randomized controlled trial of remnant closure after distal pancreatectomy: does the addition of a falciform patch and fibrin glue improve outcomes?. Journal of Gastrointestinal Surgery 2013;17(1):102‐9. - PubMed
D'Andrea 1994 {published data only}
    1. D'Andrea AA, Costantino V, Sperti C, Pedrazzoli S. Human fibrin sealant in pancreatic surgery: it is useful in preventing fistulas? A prospective randomized study. Italian Journal of Gastroenterology 1994;26(6):283‐6. - PubMed
Lillemoe 2004 {published data only}
    1. Lillemoe KD, Cameron JL, Kim MP, Campbell KA, Sauter PK, Coleman JA, et al. Does fibrin glue sealant decrease the rate of pancreatic fistula after pancreaticoduodenectomy? Results of a prospective randomized trial. Journal of Gastrointestinal Surgery 2004;8(7):772‐4. - PubMed
Martin 2013 {published data only}
    1. Martin I, Au K. Does fibrin glue sealant decrease the rate of anastomotic leak after a pancreatoduodenectomy? Results of a prospective randomized trial. HPB: Official Journal of the International Hepato Pancreato Biliary Association 2013;15(8):561‐6. - PMC - PubMed
Montorsi 2012 {published data only}
    1. Montorsi M, Zerbi A, Bassi C, Capussotti L, Coppola R, Sacchi M, et al. Efficacy of an absorbable fibrin sealant patch (TachoSil) after distal pancreatectomy: a multicenter, randomized, controlled trial. Annals of Surgery 2012;256(5):853‐60. - PubMed
Park 2016 {published data only}
    1. Park JS, Lee DH, Jang JY, Han Y, Yoon DS, Kim JK, et al. Use of TachoSil(®) patches to prevent pancreatic leaks after distal pancreatectomy: a prospective, multicenter, randomized controlled study. Journal of Hepato‐Biliary‐Pancreatic Sciences 2016;23(2):110‐7. - PubMed
Sa Cunha 2015 {published data only}
    1. Sa Cunha A, Carrere N, Meunier B, Fabre JM, Sauvanet A, Pessaux P, et al. Stump closure reinforcement with absorbable fibrin collagen sealant sponge (TachoSil) does not prevent pancreatic fistula after distal pancreatectomy: the FIABLE multicenter controlled randomized study. American Journal of Surgery 2015;210(4):739‐48. - PubMed
Schindl 2018 {published data only}
    1. Schindl M, Függer R, Götzinger P, Längle F, Zitt M, Stättner S, et al. Randomized clinical trial of the effect of a fibrin sealant patch on pancreatic fistula formation after pancreatoduodenectomy. British Journal of Surgery 2018;105(7):811‐9. - PMC - PubMed
Suc 2003 {published data only}
    1. Suc B, Msika S, Fingerhut A, Fourtanier G, Hay JM, Holmières F, et al. Temporary fibrin glue occlusion of the main pancreatic duct in the prevention of intra‐abdominal complications after pancreatic resection: prospective randomized trial. Annals of Surgery 2003;237(1):57‐65. - PMC - PubMed
Suzuki 1995 {published data only}
    1. Suzuki Y, Kuroda Y, Morita A, Fujino Y, Tanioka Y, Kawamura T, et al. Fibrin glue sealing for the prevention of pancreatic fistulas following distal pancreatectomy. Archives of Surgery 1995;130(9):952‐5. - PubMed
Tran 2002 {published data only}
    1. Tran K, Van Eijck C, Di Carlo V, Hop WC, Zerbi A, Balzano G, et al. Occlusion of the pancreatic duct versus pancreaticojejunostomy: a prospective randomized trial. Annals of Surgery 2002;236(44):422‐8. - PMC - PubMed

References to studies excluded from this review

Mita 2015 {published data only}
    1. Mita K, Ito H, Murabayashi R, Asakawa H, Nabetani M, Kamasako A, et al. Use of a fibrinogen/thrombin‐based collagen fleece (TachoComb, TachoSil) with a stapled closure to prevent pancreatic fistula formation following distal pancreatectomy. Surgical Innovation 2015;22(6):601‐5. - PubMed
Ohwada 1998 {published data only}
    1. Ohwada S, Ogawa T, Tanahashi Y, Nakamura S, Takeyoshi I, Ohya T, et al. Fibrin glue sandwich prevents pancreatic fistula following distal pancreatectomy. World Journal of Surgery 1998;22(5):494‐8. - PubMed
Pavlik Marangos 2011 {published data only}
    1. Pavlik Marangos I, Røsok BI, Kazaryan AM, Rosseland AR, Edwin B. Effect of TachoSil patch in prevention of postoperative pancreatic fistula. Journal of Gastrointestinal Surgery 2011;15(8):1625‐9. - PMC - PubMed
Rehman 2016 {published data only}
    1. Rehman S, Jaques BC. Does a fibrin glue sealant decrease post‐operative pancreatic fistulae after pancreatoduodenectomy; a single centre comparative study in 100 consecutive patients undergoing Whipple's procedure by a single surgeon. HPB: the official journal of the International Hepato Pancreato Biliary Association 2016;18:e836‐e837.
    1. Rehman S, Jaques BC. Does fibrin glue sealant used during pancreaticoduodenectomy reduce post‐operative complication? Audit of 100 consecutive patients undergoing Whipple's procedure by a single surgeon. Journal of the Pancreas 2016;17(2):189‐95.
Silvestri 2015 {published data only}
    1. Silvestri S, Franchello A, Gonella F, Deiro G, Campra D, Cassine D, et al. Role of TachoSil® in distal pancreatectomy: a single center experience. Minerva Chirurgica 2015;70(3):175‐80. - PubMed
Tashiro 1987 {published data only}
    1. Tashiro S, Murata E, Hiraoka T, Nakakuma K, Watanabe E, Miyauchi Y. New technique for pancreaticojejunostomy using a biological adhesive. British Journal of Surgery 1987;74(5):392‐4. - PubMed

Additional references

Anderson 2006
    1. Anderson KE, Mack TM, Silverman DT. Cancer of the pancreas. In: Schottenfeld D, Fraumeni JF Jr editor(s). Cancer Epidemiology and Prevention. 3rd Edition. New York: Oxford University Press, 2006:721‐63.
Bassi 2005
    1. Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 2005;138(1):8‐13. - PubMed
Bassi 2017
    1. Bassi C, Marchegiani G, Dervenis C, Sarr M, Abu Hilal M, Adham M, et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery 2017;161(3):584‐91. - PubMed
Bornman 2001
    1. Bornman PC, Beckingham IJ. ABC of diseases of liver, pancreas, and biliary system: chronic pancreatitis. BMJ 2001;322(7287):660‐3. - PMC - PubMed
Braganza 2011
    1. Braganza JM, Lee SH, McCloy RF, McMahon MJ. Chronic pancreatitis. Lancet 2011;377(9772):1184–97. - PubMed
Carless 2003
    1. Carless PA, Henry DA, Anthony DM. Fibrin sealant use for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews 2003, Issue 1. [DOI: 10.1002/14651858.CD004171] - DOI - PMC - PubMed
Case 1960
    1. Case TC. Postoperative pancreatic fistula. American Journal of Surgery 1960;99(6):898‐903. - PubMed
Cheng 2014
    1. Cheng Y, Jia Q, Xiong X, He D, Cheng NS. Hepatobiliary and pancreatic: traumatic neuroma of the ampulla of Vater. Journal of Gastroenterology and Hepatology 2014;29(7):1342. - PubMed
Cheng 2017
    1. Cheng Y, Briarava M, Lai M, Wang X, Tu B, Cheng N, et al. Pancreaticojejunostomy versus pancreaticogastrostomy reconstruction for the prevention of postoperative pancreatic fistula following pancreaticoduodenectomy. Cochrane Database of Systematic Reviews 2017, Issue 9. [DOI: 10.1002/14651858.CD012257.pub2] - DOI - PMC - PubMed
Chirletti 2009
    1. Chirletti P, Caronna R, Fanello G, Schiratti M, Stagnitti F, Peparini N, et al. Pancreaticojejunostomy with application of fibrinogen/thrombin‐coated collagen patch (TachoSil) in Roux‐en‐Y reconstruction after pancreaticoduodenectomy. Journal of Gastrointestinal Surgery 2009;13(7):1399‐400. - PubMed
Chow 2010
    1. Chow A, Marshall H, Zacharakis E, Paraskeva P, Purkayastha S. Use of tissue glue for surgical incision closure: a systematic review and meta‐analysis of randomized controlled trials. Journal of the American College of Surgeons 2010;211(1):114‐25. - PubMed
Clavien 2009
    1. Clavien PA, Barkun J, Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien‐Dindo classification of surgical complications: five‐year experience. Annals of Surgery 2009;250(2):187‐96. - PubMed
Connor 2005
    1. Connor S, Alexakis N, Garden OJ, Leandros E, Bramis J, Wigmore SJ. Meta‐analysis of the value of somatostatin and its analogues in reducing complications associated with pancreatic surgery. British Journal of Surgery 2005;92(9):1059‐67. - PubMed
Deeks 2011
    1. Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Diener 2014
    1. Diener MK, Fitzmaurice C, Schwarzer G, Seiler CM, Hüttner FJ, Antes G, et al. Pylorus‐preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma. Cochrane Database of Systematic Reviews 2014, Issue 11. [DOI: 10.1002/14651858.CD006053.pub5] - DOI - PMC - PubMed
Dong 2016
    1. Dong Z, Xu J, Wang Z, Petrov MS. Stents for the prevention of pancreatic fistula following pancreaticoduodenectomy. Cochrane Database of Systematic Reviews 2016, Issue 5. [DOI: 10.1002/14651858.CD008914.pub3] - DOI - PMC - PubMed
Dragovich 2015
    1. Dragovich T, Erickson RA, Larson CR, Shabahang M. Pancreatic cancer. emedicine.medscape.com/article/280605‐overview#showall (accessed 6 February 2017).
Ferlay 2016
    1. Ferlay J, Partensky C, Bray F. More deaths from pancreatic cancer than breast cancer in the EU by 2017. Acta Oncologica 2016;55(9‐10):1158‐60. - PubMed
Fingerhut 2009
    1. Fingerhut A, Veyrie N, Ata T, Alexakis N, Leandros E. Use of sealants in pancreatic surgery: critical appraisal of the literature. Digestive Surgery 2009;26(1):7‐14. - PubMed
Forman 2011
    1. Forman D, Delaney B, Kuipers E, Malthaner R, Moayyedi P, Gardener E, et al. Cochrane Upper Gastrointestinal and Pancreatic Diseases Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2011, Issue 12. Art. No.: COLOCA.
Garg 2004
    1. Garg PK, Tandon RK. Survey on chronic pancreatitis in the Asia‐Pacific region. Journal of Gastroenterology and Hepatology 2004;19(9):998‐1004. - PubMed
GRADEpro 2015 [Computer program]
    1. Brozek J, Oxman A, Schunemann H. GRADEprofiler (GRADEpro). Version accessed 6 February 2017. Canada: Evidence Prime, 2015.
Gurusamy 2013
    1. Gurusamy KS, Koti R, Fusai G, Davidson BR. Somatostatin analogues for pancreatic surgery. Cochrane Database of Systematic Reviews 2013, Issue 4. [DOI: 10.1002/14651858.CD008370.pub3] - DOI - PMC - PubMed
Hackert 2011
    1. Hackert T, Werner J, Buchler MW. Postoperative pancreatic fistula. The Surgeon 2011;9(4):211‐7. - PubMed
Higgins 2003
    1. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analyses. BMJ 2003;327(7414):557‐60. - PMC - PubMed
Higgins 2011a
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Higgins 2011b
    1. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Hüttner 2016
    1. Hüttner FJ, Mihaljevic AL, Hackert T, Ulrich A, Büchler MW, Diener MK. Effectiveness of Tachosil(®) in the prevention of postoperative pancreatic fistula after distal pancreatectomy: a systematic review and meta‐analysis. Langenbeck's Archives of Surgery 2016;401(2):151‐9. - PubMed
Kuroki 2005
    1. Kuroki T, Tajima Y, Kanematsu T. Surgical management for the prevention of pancreatic fistula following distal pancreatectomy. Journal of Hepato‐Biliary‐Pancreatic Surgery 2005;12(4):283‐5. - PubMed
Lovisetto 2007
    1. Lovisetto F, Zonta S, Rota E, Mazzilli M, Bardone M, Bottero L, et al. Use of human fibrin glue (Tissucol) versus staples for mesh fixation in laparoscopic transabdominal preperitoneal hernioplasty: a prospective, randomized study. Annals of Surgery 2007;245(2):222‐31. - PMC - PubMed
Lowenfels 2006
    1. Lowenfels AB, Maisonneuve P. Epidemiology and risk factors for pancreatic cancer. Best Practice and Research. Clinical Gastroenterology 2006;20(2):197‐209. - PubMed
Lämsä 2008
    1. Lämsä T, Jin HT, Sand J, Nordback I. Tissue adhesives and the pancreas: biocompatibility and adhesive properties of 6 preparations. Pancreas 2008;36(3):261‐6. - PubMed
Lévy 2006
    1. Lévy P, Barthet M, Mollard BR, Amouretti M, Marion‐Audibert AM, Dyard F. Estimation of the prevalence and incidence of chronic pancreatitis and its complications. Gastroenterologie Clinique et Biologique 2006;30(6‐7):838‐44. - PubMed
McMillan 2016
    1. McMillan MT, Soi S, Asbun HJ, Ball CG, Bassi C, Beane JD, et al. Risk‐adjusted outcomes of clinically relevant pancreatic fistula following pancreatoduodenectomy: a model for performance evaluation. Annals of Surgery 2016;264(2):344‐52. - PubMed
Mobley 2002
    1. Mobley SR, Hilinski J, Toriumi DM. Surgical tissue adhesives. Facial Plastic Surgery Clinics of North America 2002;10(2):147‐54. - PubMed
Moher 2009
    1. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMAG. Preferred Reporting Items for Systematic Reviews and Meta‐Analyses: the PRISMA statement. PLOS Medicine 2009;3(3):12‐130. - PMC - PubMed
NLM 1990
    1. National Library of Medicine. Medical subject heading: fibrin tissue adhesive. ncbi.nlm.nih.gov/mesh/68015718 (accessed 6 February 2017).
Ochiai 2010
    1. Ochiai T, Sonoyama T, Soga K, Inoue K, Ikoma H, Shiozaki A, et al. Application of polyethylene glycolic acid felt with fibrin sealant to prevent postoperative pancreatic fistula in pancreatic surgery. Journal of Gastrointestinal Surgery 2010;14(5):884‐90. - PubMed
Orci 2014
    1. Orci LA, Oldani G, Berney T, Andres A, Mentha G, Morel P, et al. Systematic review and meta‐analysis of fibrin sealants for patients undergoing pancreatic resection. HPB: the official journal of the International Hepato Pancreato Biliary Association 2014;16(1):3‐11. - PMC - PubMed
Ramacciato 2011
    1. Ramacciato G, Mercantini P, Petrucciani N, Nigri GR, Kazemi A, Muroni M, et al. Risk factors of pancreatic fistula after pancreaticoduodenectomy: a collective review. American Journal of Surgery 2011;77(3):257‐69. - PubMed
Reeves 2011
    1. Reeves BC, Deeks JJ, Higgins JPT, Wells GA. Chapter 13: Including non‐randomized studies. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
RevMan 2014 [Computer program]
    1. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Riall 2008
    1. Riall TS, Reddy DM, Nealon WH, Goodwin JS. The effect of age on short‐term outcomes after pancreatic resection: a population‐based study. Annals of Surgery 2008;248(3):459‐67. - PMC - PubMed
Rickenbacher 2009
    1. Rickenbacher A, Breitenstein S, Lesurtel M, Frilling A. Efficacy of TachoSil a fibrin‐based haemostat in different fields of surgery — a systematic review. Expert Opinion on Biological Therapy 2009;9(7):897‐907. - PubMed
Schulick 2009
    1. Schulick RD, Yoshimura K. Stents, glue, etc.: is anything proven to help prevent pancreatic leaks/fistulae?. Journal of Gastrointestinal Surgery 2009;13(7):1184‐6. - PubMed
Siedentop 2001
    1. Siedentop KH, Park JJ, Shah AN, Bhattacharyya TK, O'Grady KM. Safety and efficacy of currently available fibrin tissue adhesives. American Journal of Otolaryngology 2001;22(4):230‐5. - PubMed
Smits 2015
    1. Smits FJ, Santvoort HC, Besselink MG, Borel Rinkes IH, Molenaar IQ. Systematic review on the use of matrix‐bound sealants in pancreatic resection. HPB : the official journal of the International Hepato Pancreato Biliary Association 2015;17(11):1033‐9. - PMC - PubMed
Spanier 2008
    1. Spanier BW, Dijkgraaf MG, Bruno MJ. Epidemiology, aetiology and outcome of acute and chronic pancreatitis: an update. Best Practice and Research. Clinical Gastroenterology 2008;22(1):45‐63. - PubMed
Spotnitz 2010
    1. Spotnitz WD. Fibrin sealant: past, present, and future: a brief review. World Journal of Surgery 2010;34(4):632‐4. - PubMed
Sterne 2011
    1. Sterne JAC, Egger M, Moher D (editors). Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Weniger 2016
    1. Weniger M, D'Haese JG, Crispin A, Angele MK, Werner J, et al. Autologous but not fibrin sealant patches for stump coverage reduce clinically relevant pancreatic fistula in distal pancreatectomy: a systematic review and meta‐analysis. World Journal of Surgery 2016;40(11):2771‐81. - PubMed
Zhang 2018
    1. Zhang W, He S, Cheng Y, Xia J, Lai M, Cheng N, et al. Prophylactic abdominal drainage for pancreatic surgery. Cochrane Database of Systematic Reviews 2018, Issue 6. [DOI: 10.1002/14651858.CD010583.pub4] - DOI - PMC - PubMed

References to other published versions of this review

Cheng 2012
    1. Cheng Y, Xiong X, Peng S, Wu HM, Cheng N. Fibrin sealants for the prevention of postoperative pancreatic fistula following pancreatic surgery. Cochrane Database of Systematic Reviews 2012, Issue 2. [DOI: 10.1002/14651858.CD009621] - DOI - PubMed
Cheng 2016
    1. Cheng Y, Ye M, Xiong X, Peng S, Wu HM, Cheng N, et al. Fibrin sealants for the prevention of postoperative pancreatic fistula following pancreatic surgery. Cochrane Database of Systematic Reviews 2016, Issue 2. [DOI: 10.1002/14651858.CD009621.pub2] - DOI - PubMed
Gong 2018
    1. Gong J, He S, Cheng Y, Cheng N, Gong J, Zeng Z. Fibrin sealants for the prevention of postoperative pancreatic fistula following pancreatic surgery. Cochrane Database of Systematic Reviews 2018, Issue 6. [DOI: 10.1002/14651858.CD009621.pub3] - DOI - PMC - PubMed

Publication types

MeSH terms